IFAN — Palantir Bioceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Palantir Bioceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2013 August 31st	R2014 August 31st	2015 August 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-Q	10-K	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.001	0	0.138	0	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.001	0.087	0.147	0	0
Net Property, Plant And Equipment	—	0	0.002	—	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	0.001	0.281	5.02	0	0
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.031	0.311	1.45	0	0
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.031	0.311	1.45	0	0
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.03	-0.03	3.57	0	0
Total Liabilities & Shareholders' Equity	0.001	0.281	5.02	0	0
Total Common Shares Outstanding
Total Preferred Shares Outstanding